학술논문
Subtype C ALVAC-HIV and bivalent subtype C gp120/MF59 HIV-1 vaccine in low-risk, HIV-uninfected, South African adults: a phase 1/2 trial
Document Type
Article
Author
Bekker, Linda-Gail ; Moodie, Zoe; Grunenberg, Nicole; Laher, Fatima; Tomaras, Georgia D; Cohen, Kristen W; Allen, Mary; Malahleha, Mookho; Mngadi, Kathryn; Daniels, Brodie; Innes, Craig; Bentley, Carter; Frahm, Nicole; Morris, Daryl E; Morris, Lynn; Mkhize, Nonhlanhla N; Montefiori, David C; Sarzotti-Kelsoe, Marcella; Grant, Shannon; Yu, Chenchen; Mehra, Vijay L; Pensiero, Michael N; Phogat, Sanjay; DiazGranados, Carlos A; Barnett, Susan W; Kanesa-thasan, Niranjan; Koutsoukos, Marguerite; Michael, Nelson L; Robb, Merlin L; Kublin, James G; Gilbert, Peter B; Corey, Lawrence; Gray, Glenda E; McElrath, M Juliana
Source
In The Lancet HIV July 2018 5(7):e366-e378
Subject
Language
ISSN
2352-3018